ARCHIVES

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

This article is from The Cancer Letter archive.

Vol. 32 No. 46 | December 22, 2006

Download PDF Visit The Full Archive

Related Articles

Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)

October 28, 1988

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007

NCI RFA: Tobacco Use Research Centers

December 18, 1998

Cancer Control Survey “a Flop,” Advisory committee Members Say

October 11, 1974

Who Will Determine Pay Lines For Each Program at NCI? Upton Suggests A Collective Approach

February 17, 1978

Texas Voters Approve $3 Billion In Bonds For Cancer Research.

November 9, 2007